⌘K

Login Start Free

Home/Filings/4/0001127602-19-031852

4//SEC Filing

WAREHAM JOHN P 4

Accession 0001127602-19-031852

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 2:57 PM ET

Size

19.4 KB

Accession

0001127602-19-031852

Insider Transaction Report

Form 4

Period: 2019-11-01

Director

Transactions

Exercise/Conversion
ResMed Common Stock Options
2019-11-04−5,956→ 0 total
Exercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Commmon Stock (5,956 underlying)
Exercise/Conversion
ResMed Common Stock
2019-11-04$58.24/sh+5,000$291,200→ 17,400 total
Gift
ResMed Common Stock
2019-11-04−1,100→ 11,300 total
Exercise/Conversion
ResMed Common Stock
2019-11-01$58.24/sh+9,536$555,377→ 21,936 total
Sale
ResMed Common Stock
2019-11-01$148.15/sh−9,536$1,412,730→ 12,400 total
Exercise/Conversion
ResMed Common Stock Options
2019-11-04−5,000→ 5,956 total
Exercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Commmon Stock (5,000 underlying)
Exercise/Conversion
ResMed Common Stock
2019-11-04$58.24/sh+5,956$346,877→ 18,356 total
Sale
ResMed Common Stock
2019-11-04$148.00/sh−5,956$881,488→ 12,400 total
Exercise/Conversion
ResMed Common Stock Options
2019-11-01−9,536→ 10,956 total
Exercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Commmon Stock (9,536 underlying)
Sale
ResMed Common Stock
2019-11-04$147.75/sh−5,000$738,750→ 12,400 total

Footnotes (2)

[F1]This transaction was executed in multiple trades at prices ranging from $148.00 to $148.52. The price reported above reflects the weighted average sale price.
[F2]Gift of shares to Washington University in St. Louis. Mr. Wareham has no beneficial interest, control or dispositive power over the gifted shares.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001231182

Filing Metadata

Form type: 4
Filed: Nov 4, 7:00 PM ET
Accepted: Nov 5, 2:57 PM ET
Size: 19.4 KB

View on SEC.gov